BPS2026 – A brighter future: Optimizing GFP fluorescence using deep learning

Deep learning (DL) method has been a state-of-art method for land cover mapping. However, DL is so data-hungry which makes it difficult to obtain the large amount label data feed into the process to ensure high performance. In this paper, we utilized the historical data which is the crop distribution map extracted by support vector machine algorithm as training dataset which was produced by traditional classification and was used to train a convolution neural network as a basic model, called as RSNet. Then, the basic model was fine-tuned which is usually used in this deep learning model training to improve the classification accuracy. The F1 scores of rice and maize were 78.91 % and 72.94%, respectively. The result verified that the migration ability of RSNet model is strong to produce the current year crop map using the historical labeled samples. From the fine-tuning model, higher overall classification accuracy of crop classification was achieved as 90.36%. This classification strategy brings us a bright future to map the crop distribution supported by the historical labelled dataset, which solves the data-hungry issues.

The claims that big data holds the key to enterprise successes and that Artificial Intelligence is going to replace humanity have become increasingly more popular over the past few years, both in academia and in the industry. However, while these claims may indeed capture some truth, they have also been massively oversold, or so we contend here. The goal of this paper is two-fold. First, we provide a qualified defence of the value of less data within the context of AI. This is done by carefully reviewing two distinct problems for big data driven AI, namely a) the limited track record of Deep Learning in key areas such as Natural Language Processing, b) the regulatory and business significance of being able to learn from few data points. Second, we briefly sketch what we refer to as a case of AI with humans and for humans, namely an AI paradigm whereby the systems we build are privacy-oriented and focused on human-machine collaboration, not competition. Combining our claims above, we conclude that when seen through the lens of cognitively inspired AI, the bright future of the discipline is about less data, not more, and more humans, not fewer.

Artificial intelligence (AI) refers to the area of knowledge that develops computerised models to perform tasks that typically require human intelligence. These algorithms are programmed to learn and identify patterns from “training data,” that can be subsequently applied to new datasets, without being explicitly programmed to do so. AI is revolutionising the field of medical imaging and in particular of Cardiovascular Magnetic Resonance (CMR) by providing deep learning solutions for image acquisition, reconstruction and analysis, ultimately supporting the clinical decision making. Numerous methods have been developed over recent years to enhance and expedite CMR data acquisition, image reconstruction, post-processing and analysis; along with the development of promising AI-based biomarkers for a wide spectrum of cardiac conditions. The exponential rise in the availability and complexity of CMR data has fostered the development of different AI models. Integration in clinical routine in a meaningful way remains a challenge. Currently, innovations in this field are still mostly presented in proof-of-concept studies with emphasis on the engineering solutions; often recruiting small patient cohorts or relying on standardised databases such as Multi-ethnic Study on atherosclerosis (MESA), UK Biobank and others. The wider incorporation of clinically valid endpoints such as symptoms, survival, need and response to treatment remains to be seen. This review briefly summarises the current principles of AI employed in CMR and explores the relevant prospective observational studies in cardiology patient cohorts. It provides an overview of clinical studies employing undersampled reconstruction techniques to speed up the scan encompassing cine imaging, whole-heart imaging, multi-parametric mapping and magnetic resonance fingerprinting along with the clinical utility of AI applications in image post-processing, and analysis. Specific focus is given to studies that have incorporated CMR-derived prediction models for prognostication in cardiac disease. It also discusses current limitations and proposes potential developments to enable multi-disciplinary collaboration for improved evidence-based medicine. AI is an extremely promising field and the timely integration of clinician's input in the ingenious technical investigator's paradigm holds promise for a bright future in the medical field.